Clinical trial
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
NCT01156168
Study timeline
Study start (actual)2011-04-05Date precision: day
Registry last updated2017-05-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
DNA analysisGENETIC
gene expression analysisGENETIC
polymorphism analysisGENETIC
protein expression analysisGENETIC
Sponsors & collaborators
ECOG-ACRIN Cancer Research Grouplead sponsor
National Cancer Institute (NCI)collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01156168 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.